Abstract:Objective: Recurrent pregnancy loss (RPL) patients have higher absolute numbers of decidual natural killer (dNK) cells with elevated intracellular IFN-γ levels leading to a pro-inflammatory cytokine milieu, which contributes to RPL pathogenesis. The main objective of this study was twofold: first to explore the regulatory effects and mechanisms of villus-derived exosomes (vEXOs) from induced abortion patients or RPL patients at the level of intracellular IFN-γ in dNK cells; second to determine the validity of application of vEXOs in the treatment of unexplained RPL (uRPL) through in vitro experiments and mouse models. Methods: Exosomes were isolated from villus explants by ultracentrifugation, co-cultured with dNK cells, and purified by enzymatic digestion and magnetically activated cell sorting. Flow cytometry, enzyme-linked immunosorbent assays, and RT-qPCR were used to determine IFN-γ levels. Comparative miRNA analysis of vEXOs from induced abortion (IA) and uRPL patients was used to screen potential candidates involved in dNK regulation, which was further confirmed by luciferase reporter assays. IA-vEXOs were electroporated with therapeutic miRNAs and encapsulated in a China Food and Drug Administration (CFDA)-approved hyaluronate gel (HA-Gel), which has been used as a clinical biomaterial in cell therapy for > 30 years. In vivo tracking was performed using 1,1-dioctadecyl-3,3,3,3-tetramethylindotricarbocyaine iodide (DiR) labelling. Tail-vein and uterine horn injections were used to evaluate therapeutic effects of the engineered exosomes in an abortion-prone mouse model (CBA/J × DBA/2 J). Placental growth was evaluated based on placental weight. IFN-γ mRNA levels in mouse placentas were measured by RT-qPCR. Results: IFN-γ levels were significantly higher in dNK cells of uRPL patients than in IA patients. Both uRPL-vEXOs and IA-vEXOs could be efficiently internalized by dNK cells, whereas uRPL-vEXOs could not reduce the expression of IFN-γ by dNK cells as much as IA-vEXOs. Mechanistically, miR-29a-3p was delivered by vEXOs to inhibit IFN-γ production by binding to the 3' UTR of IFN-γ mRNA in dNK cells. For in vivo treatment, application of the HA-Gel effectively prolonged the residence time of vEXOs in the uterine cavity via sustained release. Engineered vEXOs loaded with miR-29a-3p reduced the embryo resorption rate in RPL mice with no signs of systemic toxicity. Conclusion: Our study provides the first evidence that villi can regulate dNK cell production of IFN-γ via exosome-mediated transfer of miR-29a-3p, which deepens our understanding of maternal-fetal immune tolerance for pregnancy maintenance. Based on this, we developed a new strategy to mix engineered vEXOs with HA-Gel, which exhibited good therapeutic effects in mice with uRPL and could be used for potential clinical applications in uRPL treatment.

Abnormal Mir-122-5p Expression in Decidual NK Cells and Its Impact on Trophoblast Behavior: Insights into Unexplained Recurrent Pregnancy Loss

Integrative Analysis of Circulating Micrornas and the Placental Transcriptome in Recurrent Pregnancy Loss

Dysfunction of Shh signaling impaired trophoblast motility and autophagy is involved in poor placentation of recurrent miscarriage

Mirnas in Decidual NK Cells: Regulators Worthy of Attention During Pregnancy.

Down-regulation of Mir-378A-3p Induces Decidual Cell Apoptosis: a Possible Mechanism for Early Pregnancy Loss

Single-cell profiling of the human decidual immune microenvironment in patients with recurrent pregnancy loss

Decidual CXCR4+ CD56bright NK Cells As a Novel NK Subset in Maternal-Foetal Immune Tolerance to Alleviate Early Pregnancy Failure.

Pro-Inflammatory Signature in Decidua of Recurrent Pregnancy Loss Regardless of Embryonic Chromosomal Abnormalities

Decidual CXCR4 + CD56 bright NK cells as a novel NK subset in maternal–foetal immune tolerance to alleviate early pregnancy failure

Human CD56+CD39+ dNK cells support fetal survival through controlling trophoblastic cell fate: immune mechanisms of recurrent early pregnancy loss

The associations of natural killer cell functions during the embryo implantation window with pregnancy outcomes in women for whom the number of peripheral blood natural killer cells cannot be applied as a therapeutic index for immunological abnormalities in unexplained recurrent pregnancy loss

The Immune Atlas of Human Deciduas With Unexplained Recurrent Pregnancy Loss

Effect of Mir-30E Regulating NK Cell Activities on Immune Tolerance of Maternal-Fetal Interface by Targeting PRF1.

Proteomic Analysis of Decidua in Patients with Recurrent Pregnancy Loss (RPL) Reveals Mitochondrial Oxidative Stress Dysfunction

Dysfunction of CCR1<SUP>+</SUP> decidual macrophages is a potential risk factor in the occurrence of unexplained recurrent pregnancy loss

Single-cell Immune Landscape of Human Recurrent Miscarriage

Comprehensive RNA Expression Profile Analysis of Γδ T Cells from Peripheral Blood and Decidual Tissues in Normal Pregnancy (NP) Donors and Patients with Recurrent Pregnancy Loss (RPL)

The loss of dNK1/2 and EVT1 cells at the maternal-fetal Interface is associated with recurrent miscarriage

Increased levels of villus-derived exosomal miR-29a-3p in normal pregnancy than uRPL patients suppresses decidual NK cell production of interferon-γ and exerts a therapeutic effect in abortion-prone mice

Natural Killer Cell and Maternal-fetal Interface Immune Dysfunction in Recurrent Spontaneous Abortion

The Mir-410-5p /ITGA6 Axis Participates in the Pathogenesis of Recurrent Abortion by Regulating the Biological Function of Trophoblast